DR. THOMAS KINGSLEY BROWN

Data Science & Research Advisor. Since 2009, Dr. Thomas Kingsley Brown has been researching, writing, and speaking about ibogaine treatment for substance dependence, beginning with patient interviews at a treatment center in Baja California, Mexico to better understand their experiences. Supported by MAPS (the Multidisciplinary Association for Psychedelic Studies), he later carried out a Mexico-based study on outcomes for people receiving ibogaine-assisted treatment for opioid dependence. His work has appeared in a review article on ibogaine treatment in Current Drug Abuse Reviews (2013), a research article in the American Journal of Drug and Alcohol Abuse (2017), and a paper on the therapeutic role of the altered states produced by ibogaine in J. Psychedelic Studies (2019). Dr. Brown has also been invited to speak at numerous conferences, including the National Harm Reduction Conference, Horizons: Perspectives on Psychedelics, the European Ibogaine Conference, TEDx Venice Beach, the annual conference of the American Association of Addiction Psychiatry, and the 2018 Colloquium on Psychedelic Psychiatry in Stockholm. His academic background includes chemistry and anthropology, with degrees from the University of Pittsburgh, the California Institute of Technology, and UC San Diego.